Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
April 14, 2021
In the era of modern clinical development, several companies are turning towards novel and innovative approaches such...
Read article
March 26, 2021
Using External Evidence for Decision-Making for Medical Devices
Former Commissioner of the FDA, Dr. Scott Gottlieb, in several public presentations, would bemoan missed chances to...
Read article
March 2, 2021
Hybrid Bayesian and Frequentist Clinical Trial Designs
Most people know that clinical drug discovery is usually conducted using either Frequentist or Bayesian methods. These...
Read article
February 2, 2021
Bayesian Methods for Master Protocols
As the use of master protocols becomes more prevalent in drug development, Bayesian methods are extensively used to...
Read article
October 27, 2020
Bayesian Dose-Finding Designs – An Overview
Cytel recently conducted a webinar on Bayesian Dose-finding Designs for Modern Drug Development, presented by Dr. Yuan...
Read article
October 12, 2020
Bayesian Statistics and FDA Regulatory Acceptability
Cytel and Novartis are together hosting a complimentary Bayesian Virtual Symposium and an Interactive 7-part workshop....
Read article
September 30, 2020
A Virtual Event Brought to you by Cytel and Novartis on Innovations
Today, there is a need for advanced quantitative techniques to combine all available information for better decision...
Read article